Salute e Benessere

Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®

Dexlansoprazole is a proton pump inhibitor with a novel delivery system approved for the treatment of erosive esophagitis and heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD). Dexlansoprazole is a proton pump inhibitor with a novel delivery system approved for the treatment of erosive esophagitis and heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD). According to IQVIA ™, Dexilant ®30 mg sales were...
PR Newswire
15/06/2023

Springer Nature to Join Seegene's OneSystem™ Business as Strategic Partner

The OneSystem™ Business aims to provide Seegene's unique syndromic quantitative PCR technology and know-how to scientists worldwide, enabling them to develop a variety of customized products addressing local needs. The goal of the OneSystem™ Business is to create a world free from all diseases, including cancer and infectious diseases, not limited to humans but all organisms. As part of the OneSystem™ Business initiative, Seegene has recently signed partnership agreements with leading diagnostic…
PR Newswire
15/06/2023

Life Molecular Imaging Announces New Data on Amyloid PET Quantification

As a result of these compelling findings, an updated label for NeuraCeq® was approved for use of PET scan quantification as an adjunct to visual assessment in the European Union (EU) and the United Kingdom (UK). The Committee for Medicinal Products for Human Use (CHMP) considered the use of approved CE marked software for quantitation appropriate to provide supplemental information when the reading physician requires further assistance in guiding the image assessment. In response to this update…
PR Newswire
15/06/2023

Biomarkers Market to Grow Significantly by 2029- Brandessence Market Research

Key Takeaways Key Takeaways Biomarkers Market was worthUSD 36.3 Billionin 2018 and expected to reachUSD 91.4 Billionby 2025 with a CAGR of 14.1% during the forecast period. Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/444 Elaborating the Key Trends and Dynamics of Biomarkers Market Escalating demand for early disease diagnosis and treatment along with the growing prevalence of chronic ailments are the primary factors aiding market...
PR Newswire
15/06/2023

Anaemia Drugs Market to Grow Exponentially by 2029 Says Brandessence Market…

Key Takeaways Key Takeaways Anaemia Drugs Market was valued atUSD 26292.3 Millionin 2018 and expected to reachUSD 55279.2 Millionby 2025 with the CAGR of 11.20% over the forecast period. Elaborating the Key Trends and Dynamics of Anaemia Drugs Market Rising prevalence of anaemia, unhealthy eating habits of the masses, and booming pharmaceutical sector are the primary factors aiding the outlook of this industry vertical. Alongside, increased susceptibility of women to...
PR Newswire
15/06/2023

IMAGIO consortium receives Innovative Health Initiative EUR 24 million grant to…

The Innovative Health Initiative has awarded a EUR 24 million grant to the IMAGIO consortium of clinical partners coordinated by Philips, with additional resources and funding from industry partners The consortium will carry out research into improving clinical outcomes through less invasive treatments for lung cancer, liver cancer and soft tissue sarcomas Amsterdam, the Netherlands– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced...
Nasdaq GlobeNewswire
15/06/2023

Biosimilars Market worth $66.9 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40 Browse in-depth TOC on "Biosimilars Market" 216 - Tables 49 - Figures 306 - Pages Biosimilars Market Scope: Monoclonal Antibodies accounted for the largest share of the drug class segment in the biosimilars market in 2022. Based on the drug class, the biosimilars market is...
PR Newswire
15/06/2023

Gray Healthcare win 'Complex Care Provider of the Year' at 2023 Health Investor…

Gray Healthcare delivers individually tailored support for people with learning disabilities, Autism, mental health conditions and brain injuries within their own homes. The Gray Healthcare clinical approach, overseen by the company's inhouse Multi-Disciplinary Team, has enabled some of the UK's most vulnerable people with the most complex care needs to finally move out of hospital settings to live safe, independent, and meaningful lives in a home of their own. Gray Healthcare delivers...
PR Newswire
15/06/2023

Berlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of…

"We are excited to welcome Dr. Oliver von Stein as our new CEO to drive the next phase of innovation and growth at Berlin Cures," said Rainer Böhm, Chairman of the Board of Directors. "We aspire to establish ourselves as a leading global force in the neutralization of functional autoantibodies (fAABs). With over two decades of unwavering dedication to functional autoantibody research, we have successfully identified a biotechnology capable of effectively neutralizing fAABs. Our…
PR Newswire
15/06/2023

Nordic Bioscience's unique biomarker PRO-C3 gets green light for further study…

Morten A. Karsdal, Chief Executive Officer of Nordic Bioscience commented:"This is the world's first blood-based tumor fibrosis biomarker for patients with aggressive solid tumors. We strongly believe in the value and performance of our PRO-C3 biomarker and are proud to receive the LoS from the FDA.This recognition aligns with our belief in the biomarker's potential. Ultimately this is all about helping patients fight cancer by supporting drug developers in bringing treatments to market…
PR Newswire
15/06/2023

The Department of Health - Abu Dhabi, Mass General Brigham, and International…

In the presence of H.E.Mansoor Al Mansoori, Chairman of the Department of Health –Abu Dhabiand Dr.Alireza Haghighi, Founding Director of the International Center for Genetic Disease, the Declaration of Collaboration was signed by Dr.Asma Ibrahim Al Mannaei, Executive Director of Research and Innovation Centre at the Department of Health –Abu Dhabiand by Dr.Paul Anderson, Interim Chief Academic Officer of Mass General Brigham on behalf of iCGD and Mass General Brigham...
PR Newswire
15/06/2023

Cantourage UK Reinforces Influential Status in UK's Medical Cannabis Market, by…

Gabriel Newman, Co-Founder & CEO of Cantourage UK, commented: "In a dynamic market that continually calls for higher standards and patient-centric approaches, our partnership with LOT 420 signifies our commitment to patients who are seeking relief from their persistent ailments. Through collaboration with experienced cultivators like LOT 420, we strengthen our resolve to deliver accessible, top-tier medical cannabis products. The launch of LOT 420's product range in Germany has received…
PR Newswire
15/06/2023

Implantica reports that two independent surgeons presented their RefluxStop™…

Presented by: Dr. med. Yves Borbély, Visceral Surgery Specialist at Inselspital, the University Hospital of Bern, Switzerland Presented by: Dr. med. Yves Borbély, Visceral Surgery Specialist at Inselspital, the University Hospital ofBern, Switzerland Conclusion: RefluxStop™ shows promising results over four years in a challenging patient population burdened with GERD and esophageal motility disorders. Conclusion: This study confirmed excellent clinical outcomes beyond one...
PR Newswire
15/06/2023

Invitation to Mendus' update on vididencel program as online and on-site events…

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will provide an update on its lead program vididencel on Tuesday, June 27, 2023. The update will take place in an online event and, separately, on-site at the company's headquarters in Stockholm, Sweden. During the events, Mendus' leadership team will present the key elements of the development path for vididencel, including the clinical trial strategy and the recently...
Nasdaq GlobeNewswire
15/06/2023

Nippon Express Europe Exhibits at LogiPharma 2023 for First Time

Photo: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 Photo: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 is one of the world's largest international pharmaceutical trade shows, focusing on issues, trends and the latest technologies in pharmaceutical and...
PR Newswire
15/06/2023

Mithra Announces New Positive Preclinical Data from CSF-1R Inhibitor Program

MithraAnnounces New Positive Preclinical Data from CSF-1R Inhibitor Program CSF-1R inhibitors show promising anti-tumor activityLead compound shows synergy with PD1 cancer immune checkpoint inhibitorPreclinical development conducted in partnership with BCI PharmaLiege, Belgium ,15June2023– 7:30 CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces new positive data from preclinical studies on...
Nasdaq GlobeNewswire
15/06/2023

Sandoz introduces Act4Biosimilars Action Plan to accelerate patient access to…

Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic treatments 1 Unregulated biocopies, legal and regulatory decisions, and misaligned incentives within healthcare delivery models contribute to barriers that prevent patients in the Americas from accessing biosimilarsNewly launched Act4Biosimilars Action Plan identifies key challenges and provides...
Nasdaq GlobeNewswire
15/06/2023

SANTECHTURE LAUNCHES DUO OF RCM SOLUTIONS FOR SAUDI MARKET

More than four million rules are embedded in the system spanning medical coding; medical necessity; insurance approval and coverage; billing and pricing; insurance policies; and provider rules. THYNK offers seamless healthcare information system (HIS) integration, covering all RCM touchpoints across the patient journey, It also focuses on the delivery of real-time and proactive denial management functionality. More than four million rules are embedded in the system spanning medical coding;...
PR Newswire
15/06/2023

Results of the Annual General Shareholder Meeting as of June 13, 2023

Results of the Annual General Shareholder Meeting as of June 13, 2023Paris, France, June 15 , 2023 – 07:00 CET – The Annual General Shareholder Meeting of Pixium Vision SA (Euronext Growth Paris - FR0011950641 - Mnemo: ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, met in Paris on June 13, 2023, and adopted all the resolutions put to the vote. These included the approval of...
Nasdaq GlobeNewswire
15/06/2023

Addex Increases Issued Share Capital to Create Treasury Shares

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland,June15 , 2023-Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development (“the Company”), announced today that it has increased its share capital from CHF 1,153,483.11 to CHF 1,329,483.11 through the issue of 17,600,000 new registered shares at a nominal value of CHF 0.01 each to Addex Pharma S.A, its...
Nasdaq GlobeNewswire
15/06/2023

New KOWOLL Kolmower M28E Robotic Lawn Mower - Redefine Lawn Care

KOWOLL Kolmower M28E makes lawn care convenient even when users are not there. Kowoll's app makes it simple to stay in touch wherever users go. Furthermore, while other cutting-edge robotic mowers require programming before their first use, the M28E is designed to be intuitive and user-friendly. It simplifies the first-time setup of the mower, providing an effortless and intuitive experience. KOWOLL Kolmower M28Emakes lawn care convenient even when users are not there. Kowoll's app makes it...
PR Newswire
15/06/2023

EW Group Signs with China's Largest Healthcare, Sinopharm

EW Group will provide its expertise and experience in research, development, formulation, and production of nutraceuticals, skincare and cosmeceuticals, and therapeutics products, while Sinopharm will leverage its global reach and distribution network to help EW Group achieve greater heights on the world stage. Over 1,000 SKUs of EW Group's proprietary products will be sold and distributed under Sinopharm. EW Group will provide its expertise and experience in research, development…
PR Newswire
15/06/2023

Consumer Healthcare Market to Reach $574.4 Billion, Globally, by 2032 at 7.5%…

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/3511 Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/3511 Prime determinants of growth An increase in demand for dietary supplements, the growing trend of self-medication, and an increase in the number of key players drive the growth of the global Consumer healthcare market. However, stringent government regulations may restrict the market growth. Moreover, a rise in the number of...
PR Newswire
14/06/2023

Philips to repurchase up to 7.1 million shares to cover long-term incentive…

Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase up to 7.1 million shares to cover certain of its obligations arising from its long-term incentive plans. At the current share price, the shares represent an amount of up to approximately EUR 132 million.The repurchases will be executed through one or more individual forward transactions, expected to be entered into in the second and/or the third quarter of 2023, in accordance...
Nasdaq GlobeNewswire
14/06/2023
Altri  Comunicati